Sputum microbiota in moderate versus severe patients with COPD

European Respiratory Journal

Volumn 43, Issue 6, 2014, Pages 1787-1790

  Galiana, Antonio ^a   Aguirre, Estefania ^a   Rodriguez, Juan Carlos ^b   Mira, Alex ^c   Santibanẽz, Miguel ^d   Candela, Inmaculada ^e   Llavero, Juana ^a   Garcinunõ, Pedro ^b   Loṕez, Francisco ^a   Ruiz, Montserrat ^a   Garcia Pachon, Eduardo ^a   Royo, Gloria ^a,f  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e Centro de Investigación Marina de Santa Pola   (Spain)

^f MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL GENE; BACTERIAL LOAD; BACTERIUM DETECTION; BIODIVERSITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE DOSAGE; GENE SEQUENCE; HUMAN; LETTER; METAGENOMICS; MICROFLORA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPECIES RICHNESS; SPUTUM MICROBIOTA; ACTINOBACTERIA; BACTEROIDETES; BIOLOGY; CLASSIFICATION; DNA SEQUENCE; GENETICS; GRAM POSITIVE BACTERIUM; METABOLISM; MICROBIOLOGY; PROTEOBACTERIA; SPUTUM;

BACTERIAL DNA; RNA 16S;

ACTINOBACTERIA; BACTEROIDETES; CLASSIFICATION; COMPUTATIONAL BIOLOGY; DNA, BACTERIAL; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIOTA; PROTEOBACTERIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SPUTUM;

EID: 84901822354     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00191513     Document Type: Letter

References (12)

1. Baquero F, Nombela C. The microbiome as a human organ. Clin Microbiol Infect 2012; 18: Suppl. 4, 2-4.
2. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
3. Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002; 417: 95-98. (Pubitemid 34498823)
4. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7: 335-336.
5. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010; 5: e8578.
6. Pragman AA, Kim HB, Reilly CS, et al. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 2012; 7: e47305.
7. Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax 2012; 67: 1075-1080.
8. Han MK, Huang YJ, Lipuma JJ, et al. Significance of the microbiome in obstructive lung disease. Thorax 2012; 67: 456-463.
9. Erb-Downward JR, Huffnagle GB, Martinez FJ. The microbiota in respiratory disease. Am J Respir Crit Care Med 2012; 185: 1037-1038.
10. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
11. Boersma WG. Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly. Eur Respir J 2012; 40: 1-3.
12. Sialer S, Adamantia L, Guerrero M, et al. Relation between chronic obstructive pulmonary disease and antibiotics. Curr Infect Dis Rep 2012; 14: 300-307.